Polycystic Ovarian Syndrome (PCOS) market growth size share trends sales revenue business opportunities and investments growth analysis

 

Polycystic Ovarian Syndrome Market Growth Overview

The Polycystic Ovarian Syndrome Market Growth is expected to witness tremendous growth owing to the rising prevalence of polycystic ovarian syndrome. Other key factors such as the growing obesity among women, increase in hormonal disorders in women, change in sedentary lifestyle, socioeconomic factors, growing consumption of unhealthy diet, increasing occurrence of diabetes in women, and others are contributing towards the growth of the market. However, factors such as high cost of diagnostic procedures, expensive treatments, and side effects associated with drugs are expected to hinder the market growth during the forecast period.

Segmentation

The global polycystic ovarian syndromes market is segmented on the basis of diagnosis, treatment, and end-user. The polycystic ovarian syndrome medicine, by diagnosis, is categorized into pelvic examination, transvaginal ultrasound, and blood tests. Blood tests are further sub-segmented into hormone levels, glucose tolerance, and cholesterol and triglyceride levels. On the basis of treatment, the symptoms of polycystic ovarian syndrome is segmented into oral contraceptives, antiandrogens, insulin-sensitizing agents, antidepressant, anti-obesity, and surgery. The surgery category includes ovarian wedge resection and laparoscopic ovarian drilling. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.     

Regional Analysis

The Americas is expected to dominate the Polycystic Ovarian Syndrome Market Growth during the forecast period. The increasing prevalence of polycystic ovarian syndrome drives the market in this region. According to the Centers for Disease Control and Prevention, the Polycystic Ovary Syndrome (PCOS) affects 6 to 12% of the American women of the childbearing age. This is expected to influence the market growth during the forecast period.  

Europe (UK, Belgium, France, and Netherlands) is the second largest in the market owing to the increasing prevalence of obesity and growing healthcare expenditure. The increasing research activities for Polycystic Ovary Syndrome (PCOS) are influencing the market growth.   EuroSciCon will hold the 5th World Congress on Polycystic Ovarian Disorder in April 2019 in Berlin, Germany to discuss diagnosis and intervention of the polycystic ovarian syndrome.

Asia-Pacific was projected to be the fastest growing region for the global Polycystic Ovarian Syndrome Market Growth in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population. The Asian Diabetes Prevention Initiative estimated that by 2030 India and China will have a diabetic patient pool with a total of half billion people. Furthermore, according to the Journal of the American Medical Association in 2013, China had 187.7 million women suffering from prediabetes. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Key Players

Some of the key players in the global Polycystic Ovarian Syndrome Market Growth are Bayer AG, AstraZeneca plc, Abbott, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals, Inc., Sanofi, Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA, Bristol-Myer Squibb Company, Neurocrine Biosciences, Inc., Reliance Life Sciences Pvt. Ltd. Pfizer, Inc., Novartis AG, and Shire Plc.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/orthopedic-implant-market-838

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Asthma Inhaler Device market poised to achieve significant growth in the years to come

  Asthma Inhaler Device Market Overview The global asthma inhaler devices market is likely to expand at 5.2 % CAGR during the forecast period (2017-2022) owing to the increasing prevalence of asthma among the crowd, asserts Market Research Future (MRFR). An inflammatory disease of the lungs, asthma is characterized by the difficulty faced while breathing. The symptoms of asthma are often triggered with exposure to allergens such as ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke. Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes airways sensitive to irritations. Drivers and Constraints Impacting the Market With the increasing prevalence of asthma especially among the children, the market is likely to propel over the assessment period. For instance, around 9 million children under five years of age die every year due to the presence of lung diseases. The increasing disposable income and rising preference for combinati...
Read more

Surgical Drapes and Gowns Market Trends with worldwide Industry Analysis, Features, Top Player and Forecast 2030

Image
  Surgical Drapes and Gowns Market Overview The Global Surgical Drapes and Gowns anticipated to have held a market value of USD 2.23 billion in the year 2017 and is expected to grow at a CAGR of 4.4% during the forecast period. Surgical drapes and surgical gowns are used during surgery to maintain sterile surgical field and reduce the risk of contamination and prevention of surgical site infection. Surgical drapes and surgical gowns are used by patients and healthcare professional such as, nurses and doctors. Hospitals, clinics and ambulatory surgical centers are the major end user of the surgical drapes and surgical gowns products. Similarly, According to Public Health England, during 2016 to 2017 around 139,691 procedures were performed in NHS based hospitals in England and about 1,635 surgical site infections (SSIs) detected during the same period. Increasing number of surgeries in healthcare settings and high incidences of hospital-acquired infections are expec...
Read more

Blood Grouping Reagents Market is Expected to Grow at a CAGR of 7.74% by 2027

  Blood Grouping Reagents Market Overview The global blood grouping reagents market is expected to register a CAGR of   7.74%  during the forecast period and is expected to hit USD 2,642.17 million by 2027. Blood grouping reagents are solutions that can be used to determine ABO, Rhesus, Kell and MNS blood groups These classifications of human blood are all based on the presence or absence of certain antigens on the surface of red blood cells. The growth of the global blood grouping reagents market is expected to be driven by increasing prevalence of chronic disorders, increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725 Segment Analysis The global blood grouping reagents market is mainly segmented into product, technique, and test type, end user. On the basis of product, the blood groupin...
Read more